CG140 Opioids in palliative care: Online learning resource Opioids (MHRA)
This resource was developed independently by the Medicines and Healthcare products Regulatory Agency (MHRA) and not directly from the NICE guidance. The content reflects the NICE guidance, with additional information, and facilitates its implementation.
Opioids are prescribed very widely, mainly for managing pain. This module identifies the most important hazards of opioids and informs on actions that health professionals can take in order to anticipate, minimise and manage the risks.
Some of the advice in this module on the risks of opioids may not apply in the palliative care setting. Also, infrequent effects which occur on chronic treatment, such as hyperalgesia, myoclonus, and endocrine derangement are not covered.
NICE has undertaken a check of the resource at the point at which this link was published and is satisfied that it broadly supports the guidance. However NICE is unable to confirm that all of the content at any one time accurately reflects the guidance, and therefore no guarantees are given by NICE in this regard. If an individual clinician has any queries or concerns about the relationship between NICE guidance and this educational resource they should always refer to the original guidance published by NICE, and this should in all cases be regarded as the only definitive statement of the guidance. The NICE clinical guideline may be found at www.nice.org.uk/cg140
This page was last updated: 06 September 2012